Categories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
715
Aroma Chemicals
203
Biochemicals
1003
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
89
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
Heparin lithium salt
(36120358 | 9045-22-1)
| CAS: | 9045-22-1 |
|---|---|
| Molecular Formula: | N/A |
| Molecular Weight: | N/A |
| Availablility: | In Stock |
|---|---|
| Downloads: | | |
| 36120358-1g | 1g | £124.50 | |
| Bulk Order | |||
| 36120358-1g | 1g | €174.30 | |
| Bulk Order | |||
| 36120358-1g | 1g | $186.80 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 36120358 | ||||
| Product Name | Heparin lithium salt | ||||
| Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
| CAS | 9045-22-1 | ||||
| Molecular Formula | N/A | ||||
| Molecular Weight | N/A | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 3001909100 |
Product Specification
| Heavy metals | ≤ 30PPM | ||||
| pH | 5.0 - 7.5 | ||||
| Loss on Drying | ≤ 8.0% | ||||
| Assay | ≥150.0U/mg(Dry) | ||||
| Optical Rotation | ≥＋32 | ||||
| Appearance | White or almost white powder, moderately hygroscopic | ||||
| Identification (IR) | Conforms to Reference | ||||
| Origin | Porcine intestinal mucosa |
Safety Information
| Pictograms |
|
||||
| Signal word | danger | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|